Patients with Growth-Related Disorders and Caregivers Prefer the Somapacitan Device to the Somatrogon Device: Results from a Randomized Crossover Study Assessing Device Preference and Ease of Use Following Simulated Injections

Shahid Akhtar,1 Birgitte Berg,2 Johan Medina,3 Maya Nicole Gonczi,4 Sophie Hamilton,5 Emily Hildebrand,4 Nicky Kelepouris,6 Jesper Skov Neergaard,7 Claus Sværke,8 Gitte Ter-Borch,2 Niklas Kahr Rasmussen3 1Devices & Digital Health, Novo Nordisk A/S, Søborg, Denmark; 2Clinical Operations, Obesity, Liv...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Akhtar S, Berg B, Medina J, Gonczi MN, Hamilton S, Hildebrand E, Kelepouris N, Neergaard JS, Sværke C, Ter-Borch G, Rasmussen NK
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Dove Medical Press 2024-10-01
סדרה:	Medical Devices: Evidence and Research
נושאים:	growth hormone deficiency long-acting growth hormone device preference ease of use somapacitan somatrogon
גישה מקוונת:	https://www.dovepress.com/patients-with-growth-related-disorders-and-caregivers-prefer-the-somap-peer-reviewed-fulltext-article-MDER
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!